10 20 30 40 50 60 70 80 2RH1 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER MEMBRANE PROTEIN / HYDROLASE 05-OCT-07 2RH1
TITLE HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN B2-ADRENERGIC G PROTEIN- TITLE 2 COUPLED RECEPTOR.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2-ADRENERGIC RECEPTOR/T4-LYSOZYME CHIMERA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-2 ADRENERGIC RECEPTOR, BETA-2 ADRENOCEPTOR, BETA-2 COMPND 5 ADRENORECEPTOR / LYSIS PROTEIN, MURAMIDASE, ENDOLYSIN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN,; SOURCE 4 ORGANISM_TAXID: 9606,10665; SOURCE 5 STRAIN: ,; SOURCE 6 GENE: ADRB2, ADRB2R, B2AR / E; SOURCE 7 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 8 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1; SOURCE 12 OTHER_DETAILS: THE CONSTRUCT HAS BEEN OBTAINED BY OVERLAPPING SOURCE 13 EXTENSION PCR
KEYWDS GPCR, 7TM, ADRENERGIC, FUSION, LIPIDIC CUBIC PHASE, LIPIDIC, KEYWDS 2 MESOPHASE, CHOLESTEROL, MEMBRANE PROTEIN, MEMBRANE PROTEIN - KEYWDS 3 HYDROLASE COMPLEX, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE KEYWDS 4 INITIATIVE, ACCELERATED TECHNOLOGIES CENTER FOR GENE TO 3D KEYWDS 5 STRUCTURE, ATCG3D
EXPDTA X-RAY DIFFRACTION
AUTHOR V.CHEREZOV,D.M.ROSENBAUM,M.A.HANSON,S.G.F.RASMUSSEN,F.S.THIAN, AUTHOR 2 T.S.KOBILKA,H.J.CHOI,P.KUHN,W.I.WEIS,B.K.KOBILKA,R.C.STEVENS, AUTHOR 3 ACCELERATED TECHNOLOGIES CENTER FOR GENE TO 3D STRUCTURE (ATCG3D), AUTHOR 4 GPCR NETWORK (GPCR)
REVDAT 9 08-AUG-12 2RH1 1 REMARK REVDAT 8 13-JUL-11 2RH1 1 VERSN REVDAT 7 01-SEP-09 2RH1 1 AUTHOR KEYWDS TITLE REMARK REVDAT 6 24-FEB-09 2RH1 1 VERSN REVDAT 5 07-OCT-08 2RH1 1 REMARK REVDAT 4 11-DEC-07 2RH1 1 REMARK REVDAT 3 04-DEC-07 2RH1 1 JRNL REVDAT 2 06-NOV-07 2RH1 1 JRNL HELIX SHEET REVDAT 1 30-OCT-07 2RH1 0
JRNL AUTH V.CHEREZOV,D.M.ROSENBAUM,M.A.HANSON,S.G.RASMUSSEN,F.S.THIAN, JRNL AUTH 2 T.S.KOBILKA,H.J.CHOI,P.KUHN,W.I.WEIS,B.K.KOBILKA,R.C.STEVENS JRNL TITL HIGH-RESOLUTION CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN JRNL TITL 2 BETA2-ADRENERGIC G PROTEIN-COUPLED RECEPTOR. JRNL REF SCIENCE V. 318 1258 2007 JRNL REFN ISSN 0036-8075 JRNL PMID 17962520 JRNL DOI 10.1126/SCIENCE.1150577
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.M.ROSENBAUM,V.CHEREZOV,M.A.HANSON,S.G.F.RASMUSSEN, REMARK 1 AUTH 2 F.S.THIAN,T.S.KOBILKA,H.J.CHOI,X.J.YAO,W.I.WEIS,R.C.STEVENS, REMARK 1 AUTH 3 B.K.KOBILKA REMARK 1 TITL GPCR ENGINEERING YIELDS HIGH-RESOLUTION STRUCTURAL INSIGHTS REMARK 1 TITL 2 INTO BETA2 ADRENERGIC RECEPTOR FUNCTION. REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN
REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 26506 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1310 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1829 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3543 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 213 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 63.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.43000 REMARK 3 B22 (A**2) : -3.46000 REMARK 3 B33 (A**2) : 4.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.26000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.295 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.220 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.203 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 18.501 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3843 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2622 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5219 ; 1.500 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6377 ; 4.099 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 441 ; 3.876 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 154 ;31.604 ;23.182 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 627 ;11.383 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;12.164 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 610 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4008 ; 0.001 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 804 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 926 ; 0.187 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2443 ; 0.194 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1935 ; 0.180 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 1580 ; 0.107 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 194 ; 0.164 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.155 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 29 ; 0.140 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.192 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2884 ; 2.352 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 896 ; 0.097 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3571 ; 2.767 ; 2.500 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1974 ; 4.582 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1648 ; 5.849 ; 2.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1002 A 1011 REMARK 3 RESIDUE RANGE : A 1062 A 1161 REMARK 3 ORIGIN FOR THE GROUP (A): -23.6840 58.4050 30.4850 REMARK 3 T TENSOR REMARK 3 T11: -0.2208 T22: -0.2598 REMARK 3 T33: -0.7033 T12: 0.0432 REMARK 3 T13: -0.0594 T23: -0.0241 REMARK 3 L TENSOR REMARK 3 L11: 3.1220 L22: 2.6914 REMARK 3 L33: 5.9787 L12: 0.8643 REMARK 3 L13: 0.6146 L23: -0.8632 REMARK 3 S TENSOR REMARK 3 S11: -0.1453 S12: -0.2225 S13: 0.2116 REMARK 3 S21: 0.0984 S22: -0.0656 S23: -0.0133 REMARK 3 S31: -0.1849 S32: -0.1761 S33: 0.2109 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1012 A 1061 REMARK 3 ORIGIN FOR THE GROUP (A): -35.0580 69.0010 11.9610 REMARK 3 T TENSOR REMARK 3 T11: 0.0414 T22: -0.0871 REMARK 3 T33: -0.4908 T12: 0.0577 REMARK 3 T13: -0.1559 T23: -0.0085 REMARK 3 L TENSOR REMARK 3 L11: 9.6406 L22: 16.6501 REMARK 3 L33: 7.1133 L12: -6.5961 REMARK 3 L13: -0.9803 L23: 3.2882 REMARK 3 S TENSOR REMARK 3 S11: -0.1628 S12: -0.1008 S13: 0.4114 REMARK 3 S21: -0.7585 S22: -0.1058 S23: 0.7355 REMARK 3 S31: -0.6590 S32: -0.6073 S33: 0.2686 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 29 A 230 REMARK 3 RESIDUE RANGE : A 263 A 342 REMARK 3 ORIGIN FOR THE GROUP (A): -33.0740 20.0130 7.1220 REMARK 3 T TENSOR REMARK 3 T11: -0.0103 T22: -0.2341 REMARK 3 T33: -0.5401 T12: -0.0025 REMARK 3 T13: -0.0974 T23: -0.0034 REMARK 3 L TENSOR REMARK 3 L11: 2.3670 L22: 6.1551 REMARK 3 L33: 1.9314 L12: 2.1068 REMARK 3 L13: 0.8591 L23: 0.7864 REMARK 3 S TENSOR REMARK 3 S11: -0.0346 S12: 0.0267 S13: -0.2068 REMARK 3 S21: -0.5009 S22: 0.0712 S23: 0.2388 REMARK 3 S31: 0.3208 S32: 0.0002 S33: -0.0366 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. Water #548 has strong difference density but weak 2Fo- REMARK 3 Fc density.
REMARK 4 REMARK 4 2RH1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-07. REMARK 100 THE RCSB ID CODE IS RCSB044849.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-07; 18-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 78; NULL REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 27 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 23-ID-B; 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.03321; 1.03321 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL; NULL REMARK 200 OPTICS : MIRRORS; MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD; MARMOSAIC REMARK 200 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26506 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.12700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.6200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.67800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRIES 1U19, 2LZM REMARK 200 REMARK 200 REMARK: THIS STRUCTURE IS A PART OF THE ROADMAP/PSI COMMUNITY REMARK 200 OUTREACH PROGRAM, NOT A SPECIFIC PSI TARGET.
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30-35% V/V PEG 400, 0.1-0.2 M NA2SO4, REMARK 280 0.1 M BIS-TRIS PROPANE PH 6.5-7.0, 5-7% 1,4-BUTANEDIOL, 8-10% REMARK 280 CHOLESTEROL, 52-50% MONOOLEIN, PH 6.75, LIPIDIC MESOPHASE, REMARK 280 TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.15900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 84.62000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.15900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 84.62000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 520 LIES ON A SPECIAL POSITION.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -6 REMARK 465 TYR A -5 REMARK 465 LYS A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASN A 15 REMARK 465 ARG A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 HIS A 22 REMARK 465 ASP A 23 REMARK 465 VAL A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 ALA A 349 REMARK 465 TYR A 350 REMARK 465 GLY A 351 REMARK 465 ASN A 352 REMARK 465 GLY A 353 REMARK 465 TYR A 354 REMARK 465 SER A 355 REMARK 465 SER A 356 REMARK 465 ASN A 357 REMARK 465 GLY A 358 REMARK 465 ASN A 359 REMARK 465 THR A 360 REMARK 465 GLY A 361 REMARK 465 GLU A 362 REMARK 465 GLN A 363 REMARK 465 SER A 364 REMARK 465 GLY A 365
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 29 CG OD1 OD2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 341 O2 PLM A 415 1.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 86 -64.27 -100.05 REMARK 500 TYR A 141 -22.19 73.12 REMARK 500 REMARK 500 REMARK: NULL
REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE PALMITIC ACID (PLM) AND ACETAMIDE (ACM) GROUPS ARE REMARK 600 COVALENTLY LINKED TO THEIR RESPECTIVE CYSTEINE RESIDUES.
REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 12P A 416
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CAU A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BU1 A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACM A 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 412 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 414 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLM A 415 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 12P A 416
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: ATCG3D_17 RELATED DB: TARGETDB REMARK 900 RELATED ID: GPCR-15 RELATED DB: TARGETTRACK
REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE STRUCTURE IS AN INTERNAL FUSION PROTEIN WITH LYSOZYME. REMARK 999 AN OFFSET 1000 HAS BEEN ADDED TO ORIGINAL SEQUENCE DATABASE REMARK 999 RESIDUE NUMBERS (2-161) OF THE LYSOZYME PART IN COORDINATES REMARK 999 TO DISTINGUISH THE LYSOZYME PART IN THE CHAIN. THEREFORE REMARK 999 THE RESIDUES OF LYSOZYME PART HAVE NUMBERS A1002-A1161.
DBREF 2RH1 A 1 230 UNP P07550 ADRB2_HUMAN 1 230 DBREF 2RH1 A 1002 1161 UNP P00720 LYS_BPT4 2 161 DBREF 2RH1 A 263 365 UNP P07550 ADRB2_HUMAN 263 365
SEQADV 2RH1 ASP A -6 UNP P07550 EXPRESSION TAG SEQADV 2RH1 TYR A -5 UNP P07550 EXPRESSION TAG SEQADV 2RH1 LYS A -4 UNP P07550 EXPRESSION TAG SEQADV 2RH1 ASP A -3 UNP P07550 EXPRESSION TAG SEQADV 2RH1 ASP A -2 UNP P07550 EXPRESSION TAG SEQADV 2RH1 ASP A -1 UNP P07550 EXPRESSION TAG SEQADV 2RH1 ALA A 0 UNP P07550 EXPRESSION TAG SEQADV 2RH1 GLU A 187 UNP P07550 ASN 187 ENGINEERED SEQADV 2RH1 THR A 1054 UNP P00720 CYS 54 ENGINEERED SEQADV 2RH1 ALA A 1097 UNP P00720 CYS 97 ENGINEERED
SEQRES 1 A 500 ASP TYR LYS ASP ASP ASP ALA MET GLY GLN PRO GLY ASN SEQRES 2 A 500 GLY SER ALA PHE LEU LEU ALA PRO ASN ARG SER HIS ALA SEQRES 3 A 500 PRO ASP HIS ASP VAL THR GLN GLN ARG ASP GLU VAL TRP SEQRES 4 A 500 VAL VAL GLY MET GLY ILE VAL MET SER LEU ILE VAL LEU SEQRES 5 A 500 ALA ILE VAL PHE GLY ASN VAL LEU VAL ILE THR ALA ILE SEQRES 6 A 500 ALA LYS PHE GLU ARG LEU GLN THR VAL THR ASN TYR PHE SEQRES 7 A 500 ILE THR SER LEU ALA CYS ALA ASP LEU VAL MET GLY LEU SEQRES 8 A 500 ALA VAL VAL PRO PHE GLY ALA ALA HIS ILE LEU MET LYS SEQRES 9 A 500 MET TRP THR PHE GLY ASN PHE TRP CYS GLU PHE TRP THR SEQRES 10 A 500 SER ILE ASP VAL LEU CYS VAL THR ALA SER ILE GLU THR SEQRES 11 A 500 LEU CYS VAL ILE ALA VAL ASP ARG TYR PHE ALA ILE THR SEQRES 12 A 500 SER PRO PHE LYS TYR GLN SER LEU LEU THR LYS ASN LYS SEQRES 13 A 500 ALA ARG VAL ILE ILE LEU MET VAL TRP ILE VAL SER GLY SEQRES 14 A 500 LEU THR SER PHE LEU PRO ILE GLN MET HIS TRP TYR ARG SEQRES 15 A 500 ALA THR HIS GLN GLU ALA ILE ASN CYS TYR ALA GLU GLU SEQRES 16 A 500 THR CYS CYS ASP PHE PHE THR ASN GLN ALA TYR ALA ILE SEQRES 17 A 500 ALA SER SER ILE VAL SER PHE TYR VAL PRO LEU VAL ILE SEQRES 18 A 500 MET VAL PHE VAL TYR SER ARG VAL PHE GLN GLU ALA LYS SEQRES 19 A 500 ARG GLN LEU ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 20 A 500 GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 21 A 500 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 22 A 500 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 23 A 500 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 24 A 500 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 25 A 500 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 26 A 500 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 27 A 500 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 28 A 500 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 29 A 500 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 30 A 500 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 31 A 500 THR GLY THR TRP ASP ALA TYR LYS PHE CYS LEU LYS GLU SEQRES 32 A 500 HIS LYS ALA LEU LYS THR LEU GLY ILE ILE MET GLY THR SEQRES 33 A 500 PHE THR LEU CYS TRP LEU PRO PHE PHE ILE VAL ASN ILE SEQRES 34 A 500 VAL HIS VAL ILE GLN ASP ASN LEU ILE ARG LYS GLU VAL SEQRES 35 A 500 TYR ILE LEU LEU ASN TRP ILE GLY TYR VAL ASN SER GLY SEQRES 36 A 500 PHE ASN PRO LEU ILE TYR CYS ARG SER PRO ASP PHE ARG SEQRES 37 A 500 ILE ALA PHE GLN GLU LEU LEU CYS LEU ARG ARG SER SER SEQRES 38 A 500 LEU LYS ALA TYR GLY ASN GLY TYR SER SER ASN GLY ASN SEQRES 39 A 500 THR GLY GLU GLN SER GLY
HET MAL A 401 23 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET SO4 A 405 5 HET SO4 A 406 5 HET SO4 A 407 5 HET CAU A 408 22 HET BU1 A 409 6 HET BU1 A 410 6 HET ACM A 411 4 HET CLR A 412 28 HET CLR A 413 28 HET CLR A 414 28 HET PLM A 415 17 HET 12P A 416 21
HETNAM MAL MALTOSE HETNAM SO4 SULFATE ION HETNAM CAU (2S)-1-(9H-CARBAZOL-4-YLOXY)-3-(ISOPROPYLAMINO)PROPAN- HETNAM 2 CAU 2-OL HETNAM BU1 1,4-BUTANEDIOL HETNAM ACM ACETAMIDE HETNAM CLR CHOLESTEROL HETNAM PLM PALMITIC ACID HETNAM 12P DODECAETHYLENE GLYCOL
HETSYN CAU (S)-CARAZOLOL HETSYN 12P POLYETHYLENE GLYCOL PEG400
FORMUL 2 MAL C12 H22 O11 FORMUL 3 SO4 6(O4 S 2-) FORMUL 9 CAU C18 H22 N2 O2 FORMUL 10 BU1 2(C4 H10 O2) FORMUL 12 ACM C2 H5 N O FORMUL 13 CLR 3(C27 H46 O) FORMUL 16 PLM C16 H32 O2 FORMUL 17 12P C24 H50 O13 FORMUL 18 HOH *48(H2 O)
HELIX 1 1 ASP A 29 LYS A 60 1 32 HELIX 2 2 VAL A 67 MET A 96 1 30 HELIX 3 3 ASN A 103 THR A 136 1 34 HELIX 4 4 LYS A 147 MET A 171 1 25 HELIX 5 5 HIS A 178 GLU A 187 1 10 HELIX 6 6 GLN A 197 GLN A 229 1 33 HELIX 7 7 LYS A 267 ILE A 298 1 32 HELIX 8 8 LYS A 305 ARG A 328 1 24 HELIX 9 9 PRO A 330 CYS A 341 1 12 HELIX 10 10 ILE A 1003 GLU A 1011 1 9 HELIX 11 11 LEU A 1039 ILE A 1050 1 12 HELIX 12 12 LYS A 1060 ARG A 1080 1 21 HELIX 13 13 ALA A 1082 SER A 1090 1 9 HELIX 14 14 ALA A 1093 MET A 1106 1 14 HELIX 15 15 GLU A 1108 GLY A 1113 1 6 HELIX 16 16 THR A 1115 GLN A 1123 1 9 HELIX 17 17 TRP A 1126 ALA A 1134 1 9 HELIX 18 18 ARG A 1137 GLN A 1141 1 5 HELIX 19 19 PRO A 1143 THR A 1155 1 13
SHEET 1 1 4 LYS A1016 ASP A1020 0 SHEET 2 1 4 TYR A1024 GLY A1028 0 SHEET 3 1 4 HIS A1031 THR A1034 0 SHEET 4 1 4 GLY A1056 THR A1059 0
SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.05 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.06
LINK SG CYS A 265 C2 ACM A 411 1555 1555 1.61 LINK SG CYS A 341 C1 PLM A 415 1555 1555 1.62
SITE 1 AC1 9 GLU A1011 GLY A1030 HIS A1031 LEU A1032 SITE 2 AC1 9 ASP A1070 VAL A1103 PHE A1104 GLY A1107 SITE 3 AC1 9 ARG A1145 SITE 1 AC2 6 THR A 66 VAL A 67 THR A 68 ARG A 131 SITE 2 AC2 6 TYR A 141 SER A 143 SITE 1 AC3 4 PHE A 264 LYS A 270 LYS A 273 ARG A 328 SITE 1 AC4 5 PHE A1114 THR A1115 ASN A1116 SER A1117 SITE 2 AC4 5 ASN A1132 SITE 1 AC5 6 HOH A 512 HOH A 526 THR A1142 PRO A1143 SITE 2 AC5 6 ASN A1144 ARG A1145 SITE 1 AC6 3 ARG A1095 TRP A1126 THR A1155 SITE 1 AC7 3 ARG A1014 LEU A1015 LYS A1016 SITE 1 AC8 11 ASP A 113 PHE A 193 SER A 203 SER A 207 SITE 2 AC8 11 TRP A 286 PHE A 289 PHE A 290 ASN A 293 SITE 3 AC8 11 TYR A 308 ASN A 312 TYR A 316 SITE 1 AC9 4 PHE A 223 LYS A 263 PHE A 264 HIS A 269 SITE 1 BC1 3 LYS A 263 PHE A 264 CYS A 265 SITE 1 BC2 5 TYR A 70 CYS A 77 ILE A 112 ILE A 154 SITE 2 BC2 5 CLR A 414 SITE 1 BC3 2 LEU A 339 HOH A 520 SITE 1 BC4 2 ILE A 55 CLR A 412 SITE 1 BC5 2 LEU A 339 CYS A 341 SITE 1 BC6 3 HOH A 538 ASP A1072 VAL A1075
CRYST1 106.318 169.240 40.154 90.00 105.62 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009406 0.000000 0.002630 0.00000
SCALE2 0.000000 0.005909 0.000000 0.00000
SCALE3 0.000000 0.000000 0.025859 0.00000